FDA signs off on Lilly's new antibody drug, bebtelovimab, which is effective against the omicron variant
11th February 2022 Uncategorised 0 FDA signs off on Lilly’s new antibody drug, bebtelovimab, which is effective against the omicron variant
kdunleavy
Fri, 02/11/2022 – 17:32
More: FDA signs off on Lilly's new antibody drug, bebtelovimab, which is effective against the omicron variant
Source: fierce